Safe exclusion of pulmonary embolism (PE) is a common problem in acute medicine. Common care pathways usually involve the use of a pre-test probability score with a D-dimer test to aid clinical decision-making. Unfortunately, the specificity of many D-dimer assays decreases with age. This study investigates the role of an age-adjusted D-dimer of 5 x patient's age when the conventional cut-off of the assay is 230 ng/mL. Data was collected retrospectively over a 12-month period from patients who went on to have either computed tomography pulmonary angiography (CTPA) or pulmonary ventilation/perfusion (V/Q) imaging. D-dimers in patients with low or moderate Wells score were analysed for both conventional and age-adjusted cut-offs. The use of an adjusted D-dimer showed a sensitivity of 0.97 (95% CI 0.9-1.0) while the specificity increased from 0.07 (95% CI 0.04-0.11) for the conventional cut-off to 0.32 (95% CI 0.27-0.38) for the age-adjusted cut-off. Using a 5 x patient's age-adjusted D-dimer cut-off is both safe and showed an increased specificity comparable to those published previously on other D-dimer assays.
Introduction
Chest pain is a common presenting complaint to emergency and acute medicine departments and constitutes a large proportion of patients being admitted to the medical take; 1 10-15% of these patients are evaluated for pulmonary embolism (PE). 2 The annual incidence rises with age from less than five cases per 100,000 in children to around 500 cases per 100,000 in older adults over 80 years of age. 3 Pathways to investigate PE include the combined use of a pre-test probability (PTP) score and high sensitive D-dimer test (Supplementary file 1). D-dimer is a fibrin degradation product, which has a high negative predictive value for PE. 4 Unfortunately,
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D-dimer values increase with advancing age, leading to a decreased specificity and therefore a reduced ability to exclude PE in older adults. 5 The rising incidence coupled with a decreased ability to detect true negative patients through D-dimer measurements result in an increasing number of patients with further diagnostic tests performed.
A number of studies have been published with a conventional cut-off value of 500 ng/mL and an age-adjusted D-dimer cut-off value of age (in years) x10. 6, 7 In this study we are investigating the potential effect of excluding PE with a common, but different conventional D-dimer cut-off (230 ng/mL) and an age-adjusted D-dimer of age (in years) x5.
Method
Data was collected retrospectively as a quality improvement project in a district general hospital for a selected consecutive cohort of patients over the 12-month period between April 2016 and March 2017, for whom there was a clinical suspicion of PE and who underwent imaging to confirm or exclude the diagnosis. The local PACS (Picture achieving and communication system) department provided a list of all patients over the age of 50 years with a computed tomography pulmonary angiogram (CTPA) or ventilation-perfusion (V/Q) scan requested in the first 24 hours of their admission via either the emergency department or acute medical unit (n=593).
Patients were excluded from further analysis if they presented with a high PTP (n=225), with uncompleted scans (n=1) and with no D-dimer assay performed (n=38). Twenty-nine patients had no PTP recorded; however, they were included into the study since they had similar incidence of PE as the low/intermediate risk group (Table 1 ). In total, 329 patients were included in the final analysis. Table 3 .
The sensitivity of the conventional D-dimer cut-off was 1.00 (95% CI 0.95-1.00) in our cohort with a specificity of 0.07 (95% CI 0.04-0.11). The values for the age-adjusted D-dimer cut-off were 0.97 (95% CI 0.90-1.00) and 0.32 (95% CI 0.27-0.38) respectively. Negative predictive value changed little (from 1.00 [95% CI 0.81-1.00] to 0.98 [95% CI 0.92-1.00]). The full test statistics for conventional and age-adjusted cut-offs per age decade are shown in Table 4 .
The aim for this study was to investigate a 5 x age cut-off; however, calculations were also done for different age-adjusted cut-offs from 3 x patient's age to 10 x patient's age. The test statistics for these age-adjusted cut-offs are shown in Supplementary file 2.
There were two cases where the age-adjusted strategy would have wrongly resulted in the early exclusion of PE: patient 1 (82 years old, male, intermediate PTP) was diagnosed with a right-sided lobar PE, that had previously been diagnosed and the patient was already on long-term anticoagulation with warfarin, and patient 2 (73 years old, male, intermediate PTP) was diagnosed with a sub-segmental pulmonary embolus affecting just one laterality.
Discussion
This retrospective study was performed to assess the use of an age-adjusted D-dimer using the Instrumentation Lab D-dimer assay with a reported conventional cut-off value of 230 ng/ mL. Most published studies reporting on age-adjusted D-dimer used an assay with a conventional cut-off of 500 ng/mL. 6, 8, 9 Considering that our conventional cut-off is approximately half of the previously reported studies, we investigated an age-adjusted cut-off of 5 x patient's age.
The sensitivity of our age-adjusted cut-off was 97%, similar to studies by Douma et al 6 and Righini et al . 9 Increasing the cut-off to 6 x patient's age showed a similar sensitivity with a much larger gain in specificity than reported elsewhere. 6, 8, 9 Reducing the age-adjusted cut-off to 4 x patient's age increased the sensitivity minimally but halved the specificity with no change of NPV.
Pre-test probability (PTP) using a 3-level Wells score and D-dimer (HemosILTM D-dimer assay, cut-off 230 ng/mL) were recorded.
Radiology results were reported by consultant radiologists and in case of simultaneous V/Q scan and CTPA, the CTPA result was used as it is considered gold standard.
The D-dimer result was interpreted according to our conventional cut-off (230 ng/mL). In addition, an age-adjusted cut-off was analysed, which was considered negative if D-dimer was lower than a patient's age (in years) x5. Age (in years) x5 was chosen as the age-adjusted cut-off due to our local conventional cut-off being around half as the widely reported cut-off value of 500 ng/mL.
The data was collected and analysed using Microsoft Excel and R (version 3.4.3). Normal distribution was tested with ShapiroWilk test and normal distributed values are shown as mean and standard deviation, otherwise as median and interquartile range. Parametric variables were tested for significant differences with Welch's t-test (if normal distributed), otherwise a Mann-Whitney U test was used. Non-parametric variables were tested with Mann-Whitney U test. Frequencies were analysed with Chisquared test. Sensitivities, specificities, negative predictive values (NPV) and positive predictive values (PPV) are shown as value and 95% confidence interval (CI).
Results
During the 12-month study period a total of 329 patients over the age of 50 with low or moderate Wells score were imaged for suspected PE (317 CTPA [98.3%], 12 V/Q scan [1.7%]). Sixty-nine patients (21%) were diagnosed with PE. There were no differences in age or sex distribution; however, the PE group had significantly higher D-dimer levels ( Table 2 ) .
Of the 69 PEs identified, the majority affected either the lobar branches (37.68%) or the main pulmonary arteries (37.68%); Age-adjusted D-dimer in the diagnosis of PE Some authors suggest that subsegmental PE are part of the physiological filter function of the lungs and so should not be diagnosed or treated. 10 By hypothetically excluding 'false negative patients' with subsegmental PE the sensitivity would increase to 0.99 (95% CI 0.92-1.00). The largest gain from using an age-adjusted D-dimer is the increase in specificity. Using the conventional cut-off would drop the specificity from approximately 30% for patients up to 50 years of age, to under 2% for patients over 80 years of age. Righini et al showed that an age-adjusted D-dimer strategy increased the specificity back to around 30%. 9 Our 5 x patient's age-adjusted D-dimer demonstrates specificity to be similar throughout all age groups. Using an age-adjusted strategy, an additional 67 patients could have had PE excluded without any further imaging. This has the potential to avoid the potential harm associated with the radiation and contrast nephropathies (reported in up to 14% of patients after CTPA 11 ) as well as reducing the additional length of stay and further hospital costs associated with these investigations.
Recently, Lapner et al questioned the usefulness of an age-adjusted D-dimer. 12 They argued that an increase of the conventional cutoff threshold to a ' mean' D-dimer (average D-dimer cut-off of all age groups) or even using an ' inverted' age-adjusted D-dimer will provide similarly high NPVs. This is not surprising, considering the combination of a relatively low prevalence and a highly sensitive test. However, the driving force for using an age-adjusted strategy is the increase in specificity and the decrease of FP results. Another contemporary study by Farm et al investigated ageadjusted D-dimer for four different D-dimer assays and found the use of age-adjusted D-dimer approach improved specificity with maintained sensitivity in all four assays with a substantial decrease in false positives, similar to our study. 13 
Limitations of this study
Data was collected retrospectively over a 1-year period for those patients investigated with CTPAs and V/Q scans, and as such has the limitations of any retrospective, self-selecting study. There has been no prospective study with this D-dimer assay to our knowledge; however, our sensitivity/specificity and PPV/NPV are in a similar range to studies using the more traditional 500 ng/mL cut-off. 6, 8, 9 The study population was identified via our radiology department. Patients with low or moderate clinical risk scores and a negative D-dimer were not included. Therefore, our PTP is higher than in an unselected population. This shows in the rate of PEs diagnosed, which is higher than in the studies by Righini et al 9 or Penaloza et al . 14 In view of this, it is reassuring that the NPV is over 98%. The NPV will be higher in an unselected population with lower PTP. However, the specificity might be lower respectively. As a next step we would like to perform a prospective multicentre study with this D-dimer assay and age-adjusted D-dimer cut-off.
Conclusion
Using 5 x patient's age as an age-adjusted D-dimer cut-off seems safe, even in this higher risk population. It can reduce the number of patients investigated for PE by 20% and has the potential to reduce costs and harm, with the advantage of an equal specificity to the conventional cut-off for younger patients. ■
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